74 research outputs found
Rectus sheath haematoma or leaking aortic aneurysm - a diagnostic challenge: a case report
© 2009 Shaw et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens
Recommended from our members
Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk
Background: Body mass index (BMI) and diabetes are established risk factors for colorectal cancer (CRC), likely through perturbations in metabolic traits (e.g. insulin resistance and glucose homeostasis). Identification of interactions between variation in genes and these metabolic risk factors may identify novel biologic insights into CRC etiology. Methods: To improve statistical power and interpretation for gene-environment interaction (G Ă E) testing, we tested genetic variants that regulate expression of a gene together for interaction with BMI (kg/m2 ) and diabetes on CRC risk among 26 017 cases and 20 692 controls. Each variant was weighted based on PrediXcan analysis of gene expression data from colon tissue generated in the Genotype-Tissue Expression Project for all genes with heritability â„1%. We used a mixed-effects model to jointly measure the G Ă E interaction in a gene by partitioning the interactions into the predicted gene expression levels (fixed effects), and residual G Ă E effects (random effects). G Ă BMI analyses were stratified by sex as BMI-CRC associations differ by sex. We used false discovery rates to account for multiple comparisons and reported all results with FDR <0.2. Results: Among 4839 genes tested, genetically predicted expressions of FOXA1 (P = 3.15 Ă 10-5 ), PSMC5 (P = 4.51 Ă 10-4 ) and CD33 (P = 2.71 Ă 10-4 ) modified the association of BMI on CRC risk for men; KIAA0753 (P = 2.29 Ă 10-5 ) and SCN1B (P = 2.76 Ă 10-4 ) modified the association of BMI on CRC risk for women; and PTPN2 modified the association between diabetes and CRC risk in both sexes (P = 2.31 Ă 10-5 ). Conclusions: Aggregating G Ă E interactions and incorporating functional information, we discovered novel genes that may interact with BMI and diabetes on CRC risk
Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival
Colorectal cancer (CRC) is a biologically heterogeneous disease. To characterize its mutational profile, we conduct targeted sequencing of 205 genes for 2,105 CRC cases with survival data. Our data shows several findings in addition to enhancing the existing knowledge of CRC. We identify PRKCI, SPZ1, MUTYH, MAP2K4, FETUB, and TGFBR2 as additional genes significantly mutated in CRC. We find that among hypermutated tumors, an increased mutation burden is associated with improved CRC-specific survival (HR=0.42, 95% CI: 0.21-0.82). Mutations in TP53 are associated with poorer CRC-specific survival, which is most pronounced in cases carrying TP53 mutations with predicted 0% transcriptional activity (HR=1.53, 95% CI: 1.21-1.94). Furthermore, we observe differences in mutational frequency of several genes and pathways by tumor location, stage, and sex. Overall, this large study provides deep insights into somatic mutations in CRC, and their potential relationships with survival and tumor features. Large scale sequencing study is of paramount importance to unravel the heterogeneity of colorectal cancer. Here, the authors sequenced 205 cancer genes in more than 2000 tumours and identified additional mutated driver genes, determined that mutational burden and specific mutations in TP53 are associated with survival odds
A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
Colorectal cancer risk can be impacted by genetic, environmental, and lifestyle factors, including diet and obesity. Geneenvironment interactions (G x E) can provide biological insights into the effects of obesity on colorectal cancer risk. Here, we assessed potential genome-wide G x E interactions between body mass index (BMI) and common SNPs for colorectal cancer risk using data from 36,415 colorectal cancer cases and 48,451 controls from three international colorectal cancer consortia (CCFR, CORECT, and GECCO). The G x E tests included the conventional logistic regression using multiplicative terms (one degree of freedom, 1DF test), the two-step EDGE method, and the joint 3DF test, each of which is powerful for detecting G x E interactions under specific conditions. BMI was associated with higher colorectal cancer risk. The two-step approach revealed a statistically significant GxBMI interaction located within the Formin 1/Gremlin 1 (FMN1/GREM1) gene region (rs58349661). This SNP was also identified by the 3DF test, with a suggestive statistical significance in the 1DF test. Among participants with the CC genotype of rs58349661, overweight and obesity categories were associated with higher colorectal cancer risk, whereas null associations were observed across BMI categories in those with the TT genotype. Using data from three large international consortia, this study discovered a locus in the FMN1/GREM1 gene region that interacts with BMI on the association with colorectal cancer risk. Further studies should examine the potential mechanisms through which this locus modifies the etiologic link between obesity and colorectal cancer
Exploratory genome-wide interaction analysis of non-steroidal anti-inflammatory drugs and predicted gene expression on colorectal cancer risk
Background: Regular use of nonsteroidal anti-inflammatory drugs (NSAID) is associated with lower risk of colorectal cancer. Genome-wide interaction analysis on single variants (G Ă E) has identified several SNPs that may interact with NSAIDs to confer colorectal cancer risk, but variations in gene expression levels may also modify the effect of NSAID use. Therefore, we tested interactions between NSAID use and predicted gene expression levels in relation to colorectal cancer risk.
Methods: Genetically predicted gene expressions were tested for interaction with NSAID use on colorectal cancer risk among 19,258 colorectal cancer cases and 18,597 controls from 21 observational studies. A Mixed Score Test for Interactions (MiSTi) approach was used to jointly assess G Ă E effects which are modeled via fixed interaction effects of the weighted burden within each gene set (burden) and residual G Ă E effects (variance). A false discovery rate (FDR) at 0.2 was applied to correct for multiple testing.
Results: Among the 4,840 genes tested, genetically predicted expression levels of four genes modified the effect of any NSAID use on colorectal cancer risk, including DPP10 (PGĂE = 1.96 Ă 10-4), KRT16 (PGĂE = 2.3 Ă 10-4), CD14 (PGĂE = 9.38 Ă 10-4), and CYP27A1 (PGĂE = 1.44 Ă 10-3). There was a significant interaction between expression level of RP11-89N17 and regular use of aspirin only on colorectal cancer risk (PGĂE = 3.23 Ă 10-5). No interactions were observed between predicted gene expression and nonaspirin NSAID use at FDR < 0.2.
Conclusions: By incorporating functional information, we discovered several novel genes that interacted with NSAID use
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study.
Salicylic acid (SA) has observationally been shown to decrease colorectal cancer (CRC) risk. Aspirin (acetylsalicylic acid, that rapidly deacetylates to SA) is an effective primary and secondary chemopreventive agent. Through a Mendelian randomization (MR) approach, we aimed to address whether levels of SA affected CRC risk, stratifying by aspirin use. A two-sample MR analysis was performed using GWAS summary statistics of SA (INTERVAL and EPIC-Norfolk, N = 14,149) and CRC (CCFR, CORECT, GECCO and UK Biobank, 55,168 cases and 65,160 controls). The DACHS study (4410 cases and 3441 controls) was used for replication and stratification of aspirin-use. SNPs proxying SA were selected via three methods: (1) functional SNPs that influence the activity of aspirin-metabolising enzymes; (2) pathway SNPs present in enzymes' coding regions; and (3) genome-wide significant SNPs. We found no association between functional SNPs and SA levels. The pathway and genome-wide SNPs showed no association between SA and CRC risk (OR: 1.03, 95% CI: 0.84-1.27 and OR: 1.08, 95% CI: 0.86-1.34, respectively). Results remained unchanged upon aspirin use stratification. We found little evidence to suggest that an SD increase in genetically predicted SA protects against CRC risk in the general population and upon stratification by aspirin use
Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK âAlert Level 4â phase of the B-MaP-C study
Abstract: Background: The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions. Methods: This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated âstandardâ or âCOVID-alteredâ, in the preoperative, operative and post-operative setting. Findings: Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had âCOVID-alteredâ management. âBridgingâ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2â9%) using âNHS Predictâ. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey. Conclusions: The majority of âCOVID-alteredâ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown
ConsideraciĂłn del papel de la Zona de Desarrollo PrĂłximo y el constructivismo en el apoyo al TPACK de los maestros y al uso efectivo de la tecnologĂa
This article examines Vygotskyâs (1978) Zone of Proximal Development (ZPD) and Tharp
and Gallimoreâs (1988) application of ZPD for teacher learning that can be used as a
framework to develop teachersâ and teacher candidatesâ Technological Pedagogical Content
Knowledge (TPACK). We synthesize these ideas and provide vignettes from both teachers
and teacher candidates that describe how ZPD can inform the way teachersâ TPACK is
developed. We argue that the stages of ZPD (Tharp & Gallimore, 1988) provide a helpful
framework for the development of teacher candidatesâ and in-service teachersâ TPACK
through experiential learning opportunities that include the reflection of the intersection of
technologies, pedagogies, and content knowledge. The implication of our paper includes a call
for long-term systematic examinations of strategies to support teachers and teacher candidate
development of TPACK.Este artĂculo examina la Zona de Desarrollo PrĂłximo (ZPD) de Vygotsky (1978) y la
aplicaciĂłn de la ZPD de Tharp y Gallimore (1988) para el aprendizaje docente que puede
utilizarse como marco para desarrollar el Conocimiento TecnolĂłgico PedagĂłgico del
Contenido (TPACK, siglas en inglés) de profesores y candidatos a profesores. Sintetizamos
estas ideas y proporcionamos viñetas de profesores y candidatos a profesores que describen
cĂłmo la ZPD puede indicar la forma en que se desarrolla el TPACK de los profesores.
Argumentamos que las etapas de ZPD (Tharp & Gallimore, 1988) proporcionan un marco Ăștil
para el desarrollo del TPACK de profesores candidatos y docentes en servicio a través de
oportunidades de aprendizaje experiencial que incluyen el reflejo de la intersecciĂłn de
tecnologĂas, pedagogĂas y conocimiento del contenido. La implicaciĂłn de nuestro artĂculo incluye un llamado a indagaciones sistemĂĄticas a largo plazo, de estrategias para apoyar a los
maestros y candidatos a maestros al desarrollo del TPACK
- âŠ